Travere Therapeutics (TVTX) Receivables Refunds (2019 - 2021)
Historic Receivables Refunds for Travere Therapeutics (TVTX) over the last 3 years, with Q4 2021 value amounting to $247000.0.
- Travere Therapeutics' Receivables Refunds fell 9855.91% to $247000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $247000.0, marking a year-over-year decrease of 9855.91%. This contributed to the annual value of $247000.0 for FY2021, which is 9855.91% down from last year.
- According to the latest figures from Q4 2021, Travere Therapeutics' Receivables Refunds is $247000.0, which was down 9855.91% from $405000.0 recorded in Q3 2021.
- Travere Therapeutics' 5-year Receivables Refunds high stood at $20.2 million for Q1 2020, and its period low was $247000.0 during Q4 2021.
- In the last 3 years, Travere Therapeutics' Receivables Refunds had a median value of $13.6 million in 2020 and averaged $10.1 million.
- As far as peak fluctuations go, Travere Therapeutics' Receivables Refunds soared by 112881.72% in 2020, and later tumbled by 9855.91% in 2021.
- Quarter analysis of 3 years shows Travere Therapeutics' Receivables Refunds stood at $1.4 million in 2019, then skyrocketed by 1128.82% to $17.1 million in 2020, then plummeted by 98.56% to $247000.0 in 2021.
- Its last three reported values are $247000.0 in Q4 2021, $405000.0 for Q3 2021, and $400000.0 during Q2 2021.